{
  "DOI": "10.1007/s10689-021-00256-y",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-021-00256-y",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003ePathogenic germline exonuclease domain (ED) variants of \u003cjats:italic\u003ePOLE\u003c/jats:italic\u003e and \u003cjats:italic\u003ePOLD1\u003c/jats:italic\u003e cause the Mendelian dominant condition polymerase proof-reading associated polyposis (PPAP). We aimed to describe the clinical features of all PPAP patients with probably pathogenic variants. We identified patients with a variants mapping to the EDs of \u003cjats:italic\u003ePOLE\u003c/jats:italic\u003e or \u003cjats:italic\u003ePOLD1\u003c/jats:italic\u003e from cancer genetics clinics, a colorectal cancer (CRC) clinical trial, and systematic review of the literature. We used multiple evidence sources to separate ED variants into those with strong evidence of pathogenicity and those of uncertain importance. We performed quantitative analysis of the risk of CRC, colorectal adenomas, endometrial cancer or any cancer in the former group. 132 individuals carried a probably pathogenic ED variant (105 \u003cjats:italic\u003ePOLE\u003c/jats:italic\u003e, 27 \u003cjats:italic\u003ePOLD1\u003c/jats:italic\u003e). The earliest malignancy was colorectal cancer at 14. The most common tumour types were colorectal, followed by endometrial in \u003cjats:italic\u003ePOLD1\u003c/jats:italic\u003e heterozygotes and duodenal in \u003cjats:italic\u003ePOLE\u003c/jats:italic\u003e heterozygotes. \u003cjats:italic\u003ePOLD1-\u003c/jats:italic\u003emutant cases were at a significantly higher risk of endometrial cancer than \u003cjats:italic\u003ePOLE\u003c/jats:italic\u003e heterozygotes. Five individuals with a \u003cjats:italic\u003ePOLE\u003c/jats:italic\u003e pathogenic variant, but none with a \u003cjats:italic\u003ePOLD1\u003c/jats:italic\u003e pathogenic variant, developed ovarian cancer. Nine patients with \u003cjats:italic\u003ePOLE\u003c/jats:italic\u003e pathogenic variants and one with a \u003cjats:italic\u003ePOLD1\u003c/jats:italic\u003e pathogenic variant developed brain tumours. Our data provide important evidence for PPAP management. Colonoscopic surveillance is recommended from age 14 and upper-gastrointestinal surveillance from age 25. The management of other tumour risks remains uncertain, but surveillance should be considered. In the absence of strong genotype–phenotype associations, these recommendations should apply to all PPAP patients.\u003c/jats:p\u003e",
  "alternative-id": [
    "256"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "14 December 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "7 April 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "5 May 2021"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "None of the authors report any conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "CORGI and CORGI2 have been approved by South Central Hampshire – A Research Ethics Research Ethics Committee and South Central Oxford A Research Committee, references 17/SC/0079, 06/Q1702/9. QUASAR 2 was approved by West Midlands Research Ethics Committee (Edgbaston, Birmingham, UK; REC reference: 04/MRE/11/18. We have received and archived written consent for participation/publication from every individual whose data is included from the CORGI, CORGI 2 and QUASAR 2 clinical trial. All other individual data is taken from published manuscripts which are referenced in the manuscript."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-9670-2263",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Palles",
      "given": "Claire",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Martin",
      "given": "Lynn",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Domingo",
      "given": "Enric",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chegwidden",
      "given": "Laura",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "McGuire",
      "given": "Josh",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cuthill",
      "given": "Vicky",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Heitzer",
      "given": "Ellen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kerr",
      "given": "Rachel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kerr",
      "given": "David",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kearsey",
      "given": "Stephen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Clark",
      "given": "Susan K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tomlinson",
      "given": "Ian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Latchford",
      "given": "Andrew",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "name": "The CORGI Consortium",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        5,
        5
      ]
    ],
    "date-time": "2021-05-05T03:44:48Z",
    "timestamp": 1620186288000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        3,
        29
      ]
    ],
    "date-time": "2022-03-29T19:56:43Z",
    "timestamp": 1648583803000
  },
  "funder": [
    {
      "DOI": "10.13039/100013791",
      "award": [
        "18PG0010"
      ],
      "doi-asserted-by": "publisher",
      "name": "Bowel Cancer UK"
    },
    {
      "DOI": "10.13039/100010663",
      "award": [
        "EVOCAN"
      ],
      "doi-asserted-by": "publisher",
      "name": "H2020 European Research Council"
    },
    {
      "DOI": "10.13039/501100000289",
      "award": [
        "Programme award"
      ],
      "doi-asserted-by": "publisher",
      "name": "Cancer Research UK"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        29
      ]
    ],
    "date-time": "2024-04-29T02:18:40Z",
    "timestamp": 1714357120567
  },
  "is-referenced-by-count": 31,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2021,
        5,
        5
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2022,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            5,
            5
          ]
        ],
        "date-time": "2021-05-05T00:00:00Z",
        "timestamp": 1620172800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            5,
            5
          ]
        ],
        "date-time": "2021-05-05T00:00:00Z",
        "timestamp": 1620172800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00256-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-021-00256-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00256-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "197-209",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        5,
        5
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        5,
        5
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/bjc.2011.383",
      "author": "Z Kote-Jarai",
      "doi-asserted-by": "publisher",
      "first-page": "1230",
      "issue": "8",
      "journal-title": "Br J Cancer",
      "key": "256_CR1",
      "unstructured": "Kote-Jarai Z et al (2011) BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer 105(8):1230–1234",
      "volume": "105",
      "year": "2011"
    },
    {
      "DOI": "10.1097/GIM.0b013e31821628b6",
      "author": "S Masciari",
      "doi-asserted-by": "publisher",
      "first-page": "651",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "256_CR2",
      "unstructured": "Masciari S et al (2011) Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med 13(7):651–657",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1056/NEJMra0809889",
      "author": "DAAMD D’Andrea",
      "doi-asserted-by": "publisher",
      "first-page": "1909",
      "issue": "20",
      "journal-title": "New England J Med",
      "key": "256_CR3",
      "unstructured": "D’Andrea DAAMD (2010) The fanconi anemia and breast cancer susceptibility pathways. New England J Med 362(20):1909–1919",
      "volume": "362",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ng.3287",
      "author": "RD Weren",
      "doi-asserted-by": "publisher",
      "first-page": "668",
      "issue": "6",
      "journal-title": "Nat Genet",
      "key": "256_CR4",
      "unstructured": "Weren RD et al (2015) A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet 47(6):668–671",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMc1506878",
      "author": "B Rivera",
      "doi-asserted-by": "publisher",
      "first-page": "1985",
      "issue": "20",
      "journal-title": "N Engl J Med",
      "key": "256_CR5",
      "unstructured": "Rivera B et al (2015) Biallelic NTHL1 Mutations in a Woman with Multiple Primary Tumors. N Engl J Med 373(20):1985–1986",
      "volume": "373",
      "year": "2015"
    },
    {
      "key": "256_CR6",
      "unstructured": "Kuiper, R.P., et al., NTHL1 Tumor Syndrome, in GeneReviews((R)), M.P. Adam, et al., Editors. 2020: Seattle (WA)."
    },
    {
      "DOI": "10.1038/ng.2503",
      "author": "C Palles",
      "doi-asserted-by": "publisher",
      "first-page": "136",
      "issue": "2",
      "journal-title": "Nat Genet",
      "key": "256_CR7",
      "unstructured": "Palles C et al (2013) Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 45(2):136–144",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng2085",
      "author": "I Tomlinson",
      "doi-asserted-by": "publisher",
      "first-page": "984",
      "issue": "8",
      "journal-title": "Nat Genet",
      "key": "256_CR8",
      "unstructured": "Tomlinson I et al (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39(8):984–988",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S1470-2045(16)30172-3",
      "author": "RS Kerr",
      "doi-asserted-by": "publisher",
      "first-page": "1543",
      "issue": "11",
      "journal-title": "Lancet Oncol",
      "key": "256_CR9",
      "unstructured": "Kerr RS et al (2016) Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. Lancet Oncol 17(11):1543–1557",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1002/humu.23348",
      "author": "PJ Freeman",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "issue": "1",
      "journal-title": "Hum Mutat",
      "key": "256_CR10",
      "unstructured": "Freeman PJ et al (2018) VariantValidator: accurate validation, mapping, and formatting of sequence variation descriptions. Hum Mutat 39(1):61–68",
      "volume": "39",
      "year": "2018"
    },
    {
      "DOI": "10.1093/bioinformatics/btm076",
      "author": "JS Papadopoulos",
      "doi-asserted-by": "publisher",
      "first-page": "1073",
      "issue": "9",
      "journal-title": "Bioinformatics",
      "key": "256_CR11",
      "unstructured": "Papadopoulos JS, Agarwala R (2007) COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics 23(9):1073–1079",
      "volume": "23",
      "year": "2007"
    },
    {
      "DOI": "10.1002/humu.23676",
      "author": "E Castellsague",
      "doi-asserted-by": "publisher",
      "first-page": "36",
      "issue": "1",
      "journal-title": "Hum Mutat",
      "key": "256_CR12",
      "unstructured": "Castellsague E et al (2019) Novel POLE pathogenic germline variant in a family with multiple primary tumors results in distinct mutational signatures. Hum Mutat 40(1):36–41",
      "volume": "40",
      "year": "2019"
    },
    {
      "DOI": "10.1139/g05-106",
      "author": "K Murphy",
      "doi-asserted-by": "publisher",
      "first-page": "403",
      "issue": "4",
      "journal-title": "Genome",
      "key": "256_CR13",
      "unstructured": "Murphy K et al (2006) A method to select for mutator DNA polymerase deltas in Saccharomyces cerevisiae. Genome 49(4):403–410",
      "volume": "49",
      "year": "2006"
    },
    {
      "DOI": "10.3892/ijo.2014.2410",
      "author": "A Rohlin",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "issue": "1",
      "journal-title": "Int J Oncol",
      "key": "256_CR14",
      "unstructured": "Rohlin A et al (2014) A mutation in POLE predisposing to a multi-tumour phenotype. Int J Oncol 45(1):77–81",
      "volume": "45",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10689-018-0102-6",
      "author": "PP Vande",
      "doi-asserted-by": "publisher",
      "first-page": "173",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "256_CR15",
      "unstructured": "Vande PP et al (2019) Germline mutation pN.363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma. Fam Cancer 18(2):173–178",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1021/bi961552q",
      "author": "AK Abdus Sattar",
      "doi-asserted-by": "publisher",
      "first-page": "16621",
      "issue": "51",
      "journal-title": "Biochemistry",
      "key": "256_CR16",
      "unstructured": "Abdus Sattar AK et al (1996) Functional consequences and exonuclease kinetic parameters of point mutations in bacteriophage T4 DNA polymerase. Biochemistry 35(51):16621–16629",
      "volume": "35",
      "year": "1996"
    },
    {
      "DOI": "10.1200/JCO.2014.56.5689",
      "author": "D Chubb",
      "doi-asserted-by": "publisher",
      "first-page": "426",
      "issue": "5",
      "journal-title": "J Clin Oncol",
      "key": "256_CR17",
      "unstructured": "Chubb D et al (2015) Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. J Clin Oncol 33(5):426–432",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1534/g3.118.200042",
      "doi-asserted-by": "crossref",
      "key": "256_CR18",
      "unstructured": "Barbari SR et al. (2018) Functional Analysis of Cancer Associated DNA Polymerase epsilon Variants in Saccharomyces cerevisiae. G3 Bethesda 8(3): 1019–1029."
    },
    {
      "DOI": "10.1101/gr.174789.114",
      "author": "E Shinbrot",
      "doi-asserted-by": "publisher",
      "first-page": "1740",
      "issue": "11",
      "journal-title": "Genome Res",
      "key": "256_CR19",
      "unstructured": "Shinbrot E et al (2014) Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication. Genome Res 24(11):1740–1750",
      "volume": "24",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10689-016-9925-1",
      "author": "K Wimmer",
      "doi-asserted-by": "publisher",
      "first-page": "67",
      "issue": "1",
      "journal-title": "Fam Cancer",
      "key": "256_CR20",
      "unstructured": "Wimmer K et al (2017) A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency. Fam Cancer 16(1):67–71",
      "volume": "16",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ejhg.2014.242",
      "author": "FA Elsayed",
      "doi-asserted-by": "publisher",
      "first-page": "1080",
      "issue": "8",
      "journal-title": "Eur J Hum Genet",
      "key": "256_CR21",
      "unstructured": "Elsayed FA et al (2015) Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer. Eur J Hum Genet 23(8):1080–1084",
      "volume": "23",
      "year": "2015"
    },
    {
      "DOI": "10.1002/gcc.22314",
      "author": "A Rohlin",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "issue": "1",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "256_CR22",
      "unstructured": "Rohlin A et al (2016) GREM1 and POLE variants in hereditary colorectal cancer syndromes. Genes Chromosomes Cancer 55(1):95–106",
      "volume": "55",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ijc.29396",
      "author": "I Spier",
      "doi-asserted-by": "publisher",
      "first-page": "320",
      "issue": "2",
      "journal-title": "Int J Cancer",
      "key": "256_CR23",
      "unstructured": "Spier I et al (2015) Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer 137(2):320–331",
      "volume": "137",
      "year": "2015"
    },
    {
      "DOI": "10.1093/hmg/ddu058",
      "author": "L Valle",
      "doi-asserted-by": "publisher",
      "first-page": "3506",
      "issue": "13",
      "journal-title": "Hum Mol Genet",
      "key": "256_CR24",
      "unstructured": "Valle L et al (2014) New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Hum Mol Genet 23(13):3506–3512",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1002/j.1460-2075.1991.tb07916.x",
      "author": "V Derbyshire",
      "doi-asserted-by": "publisher",
      "first-page": "17",
      "issue": "1",
      "journal-title": "EMBO J",
      "key": "256_CR25",
      "unstructured": "Derbyshire V, Grindley ND, Joyce CM (1991) The 3’-5’ exonuclease of DNA polymerase I of Escherichia coli: contribution of each amino acid at the active site to the reaction. EMBO J 10(1):17–24",
      "volume": "10",
      "year": "1991"
    },
    {
      "DOI": "10.1007/s10689-015-9803-2",
      "author": "MF Hansen",
      "doi-asserted-by": "publisher",
      "first-page": "437",
      "issue": "3",
      "journal-title": "Fam Cancer",
      "key": "256_CR26",
      "unstructured": "Hansen MF et al (2015) A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine. Fam Cancer 14(3):437–448",
      "volume": "14",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2015.75",
      "author": "F Bellido",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "issue": "4",
      "journal-title": "Genet Med",
      "key": "256_CR27",
      "unstructured": "Bellido F et al (2016) POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genet Med 18(4):325–332",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-13-2892",
      "author": "DP Kane",
      "doi-asserted-by": "publisher",
      "first-page": "1895",
      "issue": "7",
      "journal-title": "Cancer Res",
      "key": "256_CR28",
      "unstructured": "Kane DP, Shcherbakova PV (2014) A common cancer-associated DNA polymerase epsilon mutation causes an exceptionally strong mutator phenotype, indicating fidelity defects distinct from loss of proofreading. Cancer Res 74(7):1895–1901",
      "volume": "74",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.eururo.2019.01.050",
      "author": "DA Leongamornlert",
      "doi-asserted-by": "publisher",
      "first-page": "329",
      "issue": "3",
      "journal-title": "Eur Urol",
      "key": "256_CR29",
      "unstructured": "Leongamornlert DA et al (2019) Germline DNA repair gene mutations in young-onset prostate cancer cases in the UK: evidence for a more extensive genetic panel. Eur Urol 76(3):329–337",
      "volume": "76",
      "year": "2019"
    },
    {
      "DOI": "10.1038/gim.2017.265",
      "doi-asserted-by": "crossref",
      "key": "256_CR30",
      "unstructured": "Buchanan, D.D., et al., Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1. Genet Med, 2017."
    },
    {
      "DOI": "10.1136/gut.2007.136127",
      "author": "HF Vasen",
      "doi-asserted-by": "publisher",
      "first-page": "704",
      "issue": "5",
      "journal-title": "Gut",
      "key": "256_CR31",
      "unstructured": "Vasen HF et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57(5):704–713",
      "volume": "57",
      "year": "2008"
    },
    {
      "DOI": "10.1038/s41436-019-0489-y",
      "author": "EJ Crosbie",
      "doi-asserted-by": "publisher",
      "first-page": "2390",
      "issue": "10",
      "journal-title": "Genet Med",
      "key": "256_CR32",
      "unstructured": "Crosbie EJ et al (2019) The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genet Med 21(10):2390–2400",
      "volume": "21",
      "year": "2019"
    },
    {
      "key": "256_CR33",
      "unstructured": "Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer, Clinical guideline [CG164] updated: March 2017."
    },
    {
      "DOI": "10.1016/S2468-1253(16)30014-0",
      "author": "E Domingo",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "issue": "3",
      "journal-title": "Lancet Gastroenterol Hepatol",
      "key": "256_CR34",
      "unstructured": "Domingo E et al (2016) Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study. Lancet Gastroenterol Hepatol 1(3):207–216",
      "volume": "1",
      "year": "2016"
    },
    {
      "DOI": "10.1080/2162402X.2015.1072675",
      "author": "IC van Gool",
      "doi-asserted-by": "publisher",
      "first-page": "e1072675",
      "issue": "3",
      "journal-title": "Oncoimmunology",
      "key": "256_CR35",
      "unstructured": "van Gool IC, Bosse T, Church DN (2016) POLE proofreading mutation, immune response and prognosis in endometrial cancer. Oncoimmunology 5(3):e1072675",
      "volume": "5",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s13073-019-0690-2",
      "author": "SE Brnich",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "issue": "1",
      "journal-title": "Genome Med",
      "key": "256_CR36",
      "unstructured": "Brnich SE et al (2019) Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med 12(1):3",
      "volume": "12",
      "year": "2019"
    }
  ],
  "reference-count": 36,
  "references-count": 36,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-021-00256-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "21"
}